Abstract
Recent studies have shown that nefiracetam ameliorates cognitive dysfunction because of ischemia when behavioral testing occurs during treatment. We sought to determine if there was a persistent effect after treatment, by testing spatial learning of embolized rats after nefiracetam therapy. Methods: Male Sprague Dawley rats (250 to 300g) were divided into 3 categories. The control group (n = 5) underwent no surgery or cerebral embolism. The vehicle group (n = 12) was anesthetized with halothane, underwent surgery, injected with intracarotid microspheres, and given orally 5mL/kg of the vehicle (0.5% aqueous sodium carboxymethyl cellulose) for 21 days. The nefiracetam group (n = 12) was embolized and treated orally with 30 mg/kg nefiracetam (6mg/mL in vehicle) for 21 days. Outcome was determined with visual spatial learning after the end of treatment. Results: Embolization caused a significant impairment in visual spatial learning, which nefiracetam completely ameliorated (group main effect, F2,444 = 6.4, P =.002). Mean latency to the escape was 35 ± 6 seconds for the vehicle group versus 18 ± 4 seconds for the nefiracetam group, after 4 days of testing. This effect persisted after a further interval of 10 days (retention test). A reversal test (to assess working memory for new information) yielded mean latencies of 26 ± 6 seconds for the control group, 49 ± 5 seconds for vehicle, and 25 ± 4 seconds for nefiracetam (group main effect, F2,109 = 8.0, P =.0005, Newman-Keuls, P <.05), showing that both the control and nefiracetam groups were different from the vehicle group. Conclusion: Nefiracetam therapy improves the learning behavior of embolized rats. The results are not caused by an activating effect of the drug because the animals are tested after the treatment period is over and because the beneficial effect is seen using the delayed retention test. Finally, working memory is markedly preserved by nefiracetam, an effect observed several weeks after treatment. Copyright © 2001 by National Stroke Association
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
